These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 1630680)
1. [The Study Group of Quinapril in Arterial Hypertension. The Steering Committee]. Ambrosioni E; Brusca A; Caponnetto S; Condorelli M; Corea L; Dal Palù C; Fogari R; Mameli P; Mancia G; Neri Serneri GG Minerva Cardioangiol; 1992 Mar; 40(3):85-96. PubMed ID: 1630680 [TBL] [Abstract][Full Text] [Related]
2. Controlled multicenter study with quinapril, hydrochlorothiazide, and combination in patients with moderate to severe hypertension. Romero R; Castellote E; Ocón J; Wagner B J Cardiovasc Pharmacol; 1995 Jul; 26(1):114-8. PubMed ID: 7564350 [TBL] [Abstract][Full Text] [Related]
3. A postmarketing surveillance evaluation of quinapril in 3742 Canadian hypertensive patients: the ACCEPT Study. Accupril Canadian Clinical Evaluation and Patient Teaching. Larochelle P; Haynes B; Maron N; Dugas S Clin Ther; 1994; 16(5):838-53. PubMed ID: 7859244 [TBL] [Abstract][Full Text] [Related]
4. The rapidity of drug dose escalation influences blood pressure response and adverse effects burden in patients with hypertension: the Quinapril Titration Interval Management Evaluation (ATIME) Study. ATIME Research Group. Flack JM; Yunis C; Preisser J; Holmes CB; Mensah G; McLean B; Saunders E Arch Intern Med; 2000 Jun; 160(12):1842-7. PubMed ID: 10871979 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin converting enzyme inhibitors as initial monotherapy in severe hypertension. Quinapril and captopril. Frishman WH; Greenberg S Am J Hypertens; 1991 Oct; 4(10 Pt 1):827-31. PubMed ID: 1747216 [TBL] [Abstract][Full Text] [Related]
6. Long-term safety and efficacy of moexipril alone and in combination with hydrochlorothiazide in elderly patients with hypertension. White WB; Stimpel M J Hum Hypertens; 1995 Nov; 9(11):879-84. PubMed ID: 8583466 [TBL] [Abstract][Full Text] [Related]
7. Quinapril versus atenolol in the treatment of mild to moderate essential hypertension. Bahena JH; Estrella ME; Muñoz M Clin Ther; 1992; 14(4):527-36. PubMed ID: 1525787 [TBL] [Abstract][Full Text] [Related]
8. Speed and duration of dose titration with the angiotensin converting enzyme inhibitor quinapril: relationship with efficacy in patients with moderate hypertension. Weir MR J Hum Hypertens; 1994 Sep; 8(9):725-30. PubMed ID: 7807504 [TBL] [Abstract][Full Text] [Related]
9. [A comparative study of the effects of lisinopril and quinapril administered once a day in essential hypertension]. De Cesaris R; Ranieri G; Andriani A; Chiarappa R Minerva Med; 1990; 81(7-8):541-6. PubMed ID: 2166253 [TBL] [Abstract][Full Text] [Related]
10. [A comparative study of the efficacy of lisinopril versus quinapril in controlling light to moderate arterial hypertension. A follow-up with ABPM]. Motero Carrasco J Rev Esp Cardiol; 1995 Nov; 48(11):746-53. PubMed ID: 8532944 [TBL] [Abstract][Full Text] [Related]
11. Quinapril, hydrochlorothiazide, and combination in patients with moderate to severe hypertension. Lenz T; Schulte KL; Wagner B; Lilienthal J; Gotzen R Eur Heart J; 1994 Jul; 15(7):940-6. PubMed ID: 7925516 [TBL] [Abstract][Full Text] [Related]
12. Comparison of quinapril and atenolol as single drugs or in combination with hydrochlorothiazide in moderate to severe hypertensives, using automated ambulatory monitoring. Lacourcière Y; Lefebvre J; Provencher P; Poirier L Br J Clin Pharmacol; 1993 Feb; 35(2):121-7. PubMed ID: 8443029 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the antihypertensive efficacy and tolerability of moexipril, a new ACE inhibitor, compared to hydrochlorothiazide in elderly patients. Persson B; Stimpel M Eur J Clin Pharmacol; 1996; 50(4):259-64. PubMed ID: 8803515 [TBL] [Abstract][Full Text] [Related]
14. Quinapril hydrochloride effects on renal function in patients with renal dysfunction and hypertension: a drug-withdrawal study. Miller MA; Texter M; Gmerek A; Robbins J; Shurzinske L; Canter D Cardiovasc Drugs Ther; 1994 Apr; 8(2):271-5. PubMed ID: 7918140 [TBL] [Abstract][Full Text] [Related]
15. Effect of quinapril on the albumin excretion rate in patients with mild to moderate essential hypertension. Multicenter Study Group. Larochelle P Am J Hypertens; 1996 Jun; 9(6):551-9. PubMed ID: 8783779 [TBL] [Abstract][Full Text] [Related]
16. Modification of cardiovascular risk factors during antihypertensive treatment: a multicentre trial with quinapril. Manzato E; Capurso A; Crepaldi G J Int Med Res; 1993; 21(1):15-25. PubMed ID: 8319817 [TBL] [Abstract][Full Text] [Related]
17. Comparison of amlodipine and quinapril on ambulatory blood pressure and platelet function in hypertension. Ding YA; Chang SM; Chou TC J Hum Hypertens; 1995 Aug; 9(8):637-41. PubMed ID: 8523379 [TBL] [Abstract][Full Text] [Related]
18. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders. Plosker GL; Sorkin EM Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326 [TBL] [Abstract][Full Text] [Related]
19. Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders. Culy CR; Jarvis B Drugs; 2002; 62(2):339-85. PubMed ID: 11817979 [TBL] [Abstract][Full Text] [Related]
20. [Clinical-instrumental evaluation of the effects of quinapril treatment in mild-to-moderate hypertension]. Saitta A; Bonaiuto M; Mileto A; Oriti S; Campo S; Giordano G; Cinquegrani M; Saitta MN; Fodale P Clin Ter; 1990 Sep; 134(5):289-99. PubMed ID: 2149311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]